tiprankstipranks
Baudax Bio (BXRXQ)
OTHER OTC:BXRXQ
US Market

Baudax Bio (BXRXQ) Financial Statements

Compare
747 Followers

Baudax Bio Financial Overview

Baudax Bio's market cap is currently $44.00. The company's EPS TTM is $-9.164; its P/E ratio is ―; Baudax Bio is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit$ -5.74M$ -1.36M$ -1.24M$ 206.00K-
Operating Income$ -56.81M$ -19.01M$ -74.79M$ -47.07M$ -65.04M
EBITDA$ -33.58M$ -14.51M$ -72.19M$ -32.08M$ -64.64M
Net Income$ -58.80M$ -19.77M$ -76.10M$ -32.56M$ -73.67M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 10.03M$ 53.28M$ 68.73M$ 54.49M$ 35.02M
Total Debt$ 7.12M$ 8.53M$ 9.15M$ 773.00K$ 0.00
Net Debt$ 1.86M$ -7.36M$ -21.19M$ -16.97M$ 0.00
Total Liabilities$ 34.27M$ 40.05M$ 83.53M$ 70.93M$ 103.37M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -27.81M$ -13.05M$ -46.94M$ -36.81M$ -63.20M
Operating Cash Flow$ -27.79M$ -12.85M$ -46.30M$ -35.49M$ -59.75M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Baudax Bio Earnings and Revenue History

Baudax Bio Debt to Assets

Baudax Bio Cash Flow

Baudax Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis